Companies: 10,795·Total market cap: $144.5T
Organon & Co.

Organon & Co.

OGNNYSEHealthcare● Active
$13.40
+$0.04(+0.26%)
Market Cap$3.5B
P/E Ratio
52W High$13.48
52W Low$5.69

Organon & Co. (OGN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ogn · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 9 Wall Street analysts in the past 3 months

SellBuy

Hold

9 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
2
Hold
4
Sell
3
Strong Sell
0
Total: 9 · Buy rate: 22.2%

12-Month Price Target

High

$14.00

Consensus

$11.33

-15.4% upside

Low

$8.00

Median: $12 · Last Close: $13.40

The Organon & Co. (OGN) analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month OGN price target is $11.33, representing -15.4% upside from the current price of $13.40.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $11 (-15.4%)

Consensus Target

$11.33

-15.4% upside

High Target

$14

4.5%

Low Target

$8

-40.3%

Current Price

$13.40

as of today

Based on analyst price targets, the OGN stock price prediction for the next 12 months ranges from $8 to $14. The consensus OGN price forecast of $11.33 implies -15.4% upside from the current price of $13.40.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.410.06%

1-day model range: $13.4–$13.42. Peak: $13.42 (+0.06%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$9-34.2%
2028$7-47.7%
2029$6-54.1%
2030$6-57.5%
2031-59.4%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)46.9Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · OGN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$13.39BUY
MA 10$13.38BUY
MA 20$13.38BUY
MA 50$11.14BUY
MA 100$9.35BUY
MA 200$8.93BUY
Current $OGN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$13.39BUY
EMA 10$13.37BUY
EMA 20$13.13BUY
EMA 50$11.66BUY
EMA 100$10.29BUY
EMA 200$9.89BUY
Current $OGN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BNP Paribas2026-04-29
Downgrade ↓
OutperformNeutral
Piper Sandler2026-04-28
Upgrade ↑
UnderweightNeutral
Barclays2026-02-24
Maintains
UnderweightUnderweight
Morgan Stanley2025-11-11
Maintains
Equal WeightEqual Weight
JP Morgan2025-11-11
Maintains
UnderweightUnderweight
Piper Sandler2025-05-15
Maintains
OverweightOverweight
Morgan Stanley2025-05-05
Maintains
Equal WeightEqual Weight
Morgan Stanley2025-04-09
Maintains
Equal WeightEqual Weight
Barclays2025-02-14
Maintains
OverweightOverweight
Morgan Stanley2025-02-14
Maintains
Equal WeightEqual Weight

Wall Street analysts have recently issued updated ratings on Organon & Co. (OGN) stock. Of the recent 37 rating actions, 2 were upgrades and 5 were downgrades. 9 analysts currently cover OGN.

Analyst Recommendation Trends

Buy ratings101
Hold ratings12↑ +1
Sell ratings00

OGN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$6.1B

↓ 2.2% YoY

Revenue Next Year

$6.2B

↑ 1.6% YoY

EPS This Year

$3.40

EPS Next Year

$3.63

↑ 7.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast OGN EPS of $3.40 for the current fiscal year, based on estimates from 4 analysts. The OGN revenue forecast is $6.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The OGN stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OGN price target is $11.33 (-15.4% upside), with an analyst consensus of Hold.

The OGN short-term stock prediction for tomorrow is $13.41 (+0.06%). The OGN stock price prediction for 2027 estimates an average of $9. The OGN stock prediction for 2030 projects a range of $6–$6.

Organon & Co. trades on NYSE under the ticker OGN. The OGN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 22% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

OGN forecast · 8 questions

According to 9 Wall Street analysts, the average 12-month OGN price target is $11.33, with a high forecast of $14.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies -15.4% potential upside from the current price of $13.40.

OGN price targetWhat is OGN price targetOGN analyst price targetOGN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.